|
0
|
|
Cattle and human organoids reveal 2.3.4.4b H5N1 cross-species transmission potential and neuraminidase-specific neutralizing antibodies in humans.
(nature.com)
|
Li C
…
Zhou J
Nature Communications
2026-07-08
|
#influenza
#zoonosis
#organoid
#neutralization
#immunity
|
|
0
|
|
Emerged N193S mutation of PA-X protein disabled the immunity of mucosal dendritic cells for regulating virulence of clade 2.3.4.4b H5 subtype virus.
(tandfonline.com)
|
Miao X
…
Qin T
Emerging Microbes & Infections
2026-07-08
|
#influenza
#immunity
#virulence
#mutation
#dendritic cell
|
|
0
|
|
Characterization of oseltamivir-resistant A(H5N1) clade 2.3.4.4b, genotype D1.1 variants identified in poultry farms of British Columbia, Canada.
(tandfonline.com)
|
Cochin M
…
Boivin G
Emerging Microbes & Infections
2026-07-08
|
#influenza
#antiviral-resistance
#avian
#virulence
#pathogenicity
|
|
0
|
|
Multi-source machine learning for short-term influenza forecasting in Hunan Province, China: a spatiotemporal analysis using surveillance, search, meteorological and air-quality data.
(link.springer.com)
|
Sun Q
…
Luo K
BMC Infectious Diseases
2026-07-08
|
#forecasting
#influenza
#machine learning
#surveillance
#spatiotemporal
|
|
0
|
|
ALOX15 orchestrates mitochondrial antiviral immunity and serves as a host target for anti-influenza therapy.
(nature.com)
|
Weng JY
…
He RR
Nature Immunology
2026-07-08
|
#immunity
#influenza
#mitochondria
#signaling
#therapeutics
|
|
0
|
|
Isolation of Infectious Highly Pathogenic Avian Influenza A(H5N1) Virus from Fetal Bovine Serum, United States, 2025.
(wwwnc.cdc.gov)
|
Rebelo AR
…
Diel DG
Emerging Infectious Diseases
2026-07-09
|
#influenza
#contamination
#virology
#sequencing
#biosafety
|
|
0
|
|
The one-month impact of influenza infection on patient-reported symptom burden among symptomatic U.S. adults with a test-confirmed illness: a longitudinal study.
(link.springer.com)
|
Hu T
…
Sun X
BMC Infectious Diseases
2026-07-09
|
#influenza
#symptomatology
#longitudinal
#patient-reported
|
|
0
|
|
Hemagglutination-inhibition and microneutralization antibody titers as mediators of protection for cell-based and recombinant influenza vaccines.
(nature.com)
|
Zhong S
…
Cowling BJ
npj Vaccines
2026-07-09
|
#influenza
#vaccination
#immunogenicity
#antibody
#efficacy
|
|
0
|
|
Protective effects of influenza B neuraminidase antibodies against symptomatic influenza virus infection.
(academic.oup.com)
|
Rogers S
…
Martin ET
Journal of Infectious Diseases
2026-07-10
|
#influenza
#immunity
#vaccination
#antibody
#protection
|
|
0
|
|
The Effect of Prevaccination Analgesics on Influenza Vaccine Immunogenicity and Effectiveness.
(academic.oup.com)
|
Skellington CN
…
Colombo RE
Journal of Infectious Diseases
2026-07-10
|
#vaccination
#immunogenicity
#influenza
#antibody
#seroconversion
|
|
0
|
|
Intranasal and intramuscular H5-Matrix-M nanoparticle vaccines protects against highly pathogenic H5N1 influenza virus in mice.
(nature.com)
|
Pyles K
…
Boon ACM
npj Vaccines
2026-07-10
|
#vaccination
#influenza
#immunogenicity
#nanoparticles
#pandemic
|
|
0
|
|
Preclinical characterization of HEC116094, an oral inhibitor of the influenza A virus polymerase PB2 subunit.
(tandfonline.com)
|
Nie L
…
Zhang L
Emerging Microbes & Infections
2026-07-10
|
#influenza
#antiviral
#preclinical
#inhibitor
#amr
|